| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: Merck |
| Recipient: You |
| Company: Medscape Zero |
| Recipient: You |
| Company: Targeted Oncology |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Great Debates and Updates in GU Oncology |
| Recipient: You |
| Company: Clinical Care Options LLC |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: RTP |
| Recipient: You |
| Company: Academic CME |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Pfizer |
| Recipient: You |
| Company: Novartise |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Janssen |
| Recipient: You |
| Company: Tempus |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: GSK |
| Recipient: You |
| Company: GSK |
| Recipient: You |
| Company: Convergent Therapeutics |
| Recipient: You |
| Company: Novartise |
| Recipient: You |
| Company: Tango Therapeutics |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Genentech |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: PCCTC |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Bayer |
| Recipient: Your Institution |
| Company: Arvinas |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: TITLE: SYSTEMS AND METHODS FOR TISSUE IMAGING, 3676
Our File: Serial Number:
UM-14437/US-1/PRO 60/923,385
UM-14437/US-2/ORD 12/101,753
US 8,185,186 (US patent number) Systems and methods for tissue imaging (issued patent)
EP 08745653.9 (EP application number) Systems and methods for tissue imaging (pending)
CA 2683805 (Canadian application number) Systems and methods for tissue imaging (pending)
US 13/362,500 (US application number) Systems and Methods for Tissue Imaging (continuation application of US 8,185,186)
|
| Recipient: You |
| Please describe: TITLE: METHOD OF TREATING CANCER
Docket No: Serial Number:
224990/10-016P2/311733 61/481/671
Application Filed on: 5/2/2011
|
| Recipient: You |
| Please describe: TITLE: Dual Inhibition of MET and VEGF for the treatment of castration resistant prostate
cancer and osteoblastic bone metastases.
Applicant/Proprietor Exelexis, Inc.
Application No/Patent No. 11764665.4- 1464
Application No/Patent No. 11764656.2-1464
Application Filed on: 26/9/2011
|
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Bayer |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
|
| Open Payments URL: https://openpaymentsdata.cms.gov/physician/146932/summary |
|